A recent study supported by the National Institutes of Health (NIH) and published in Nature Neuroscience found that Alzheimer ...
Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.
Enrollment in a 2025 Medicare plan opened for beneficiaries today. News outlets focus on an array of changes that could lead to "benefit disruption" that consumers should know about, in particular ...
New research suggests that Medicare could save up to 74 percent of the money lost from discarded Alzheimer's drug Leqembi or ...
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...
Since Leqembi is dosed based on a patient’s weight and offered in single-use vials, about 5.8% of the drug dispensed will be ...
Lecanemab (Leqembi; Eisai/Biogen) received traditional approval from the FDA in July 2023, following an accelerated approval ...
The Indian start-up ecosystem stands at a crossroads – while businesses may be bustling, the mental health of employees – on ...
The two FDA-approved drugs have demonstrated in clinical trials the capability to slow cognitive decline by several months, The Washington Post reported Oct. 8.
A Medicare annual wellness visit (AWV) was associated with greater recognition of mild cognitive impairment in older adults, ...
Leqembi, from Japan's Eisai and its U.S. partner ... A key question in the drug’s rollout will be insurance coverage by Medicare, the federal health plan that covers 60 million seniors and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback